/ELLXF
ELLXF Stock - Elixinol Wellness Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.01+51.46%
+$0.00 (+51.46%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.75
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.29
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ELLXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.27
52W High$0.04
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $14.96M | $8.27M | $7.05M | $9.34M | $15.01M |
| Gross Profit | $5.64M | $3.42M | $-3,266,000 | $-6,255,000 | $-9,583,000 |
| Gross Margin | 37.7% | 41.4% | -46.3% | -67.0% | -63.8% |
| Operating Income | $-5,106,000 | $-6,462,000 | $-10,002,000 | $-15,609,000 | $-22,113,999 |
| Net Income | $-1,722,000 | $-7,507,000 | $-10,571,000 | $-17,025,000 | $-104,506,000 |
| Net Margin | -11.5% | -90.8% | -149.8% | -182.3% | -696.2% |
| EPS | $-0.01 | $-0.10 | $-0.03 | $-0.04 | $-0.45 |
Company Overview
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ELLXFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q4 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q3 2025 | Aug 29, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 28, 2025 | — | $0.00 | — | — |
Q4 2024 | Oct 21, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 30, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.29 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.24 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.04 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.08 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.00 | — | — |
Q1 2018 | Jan 31, 2018 | — | $-0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ELLXF
What is ELLXF's current stock price?
Elixinol Wellness Limited (ELLXF) is currently trading at $0.01 per share. The stock has moved +51.46% today.
What is the analyst price target for ELLXF?
No analyst price targets are currently available for this stock.
What sector is Elixinol Wellness Limited in?
Elixinol Wellness Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ELLXF's market cap?
Elixinol Wellness Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does ELLXF pay dividends?
No, Elixinol Wellness Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCSUI
Cannabis Suisse Corp.
$0.01
Mkt Cap: $0.0B
IDCN
Indocan Resources Inc.
$0.00
Mkt Cap: $0.0B
NGMC
Next Generation Management Corp.
$0.00
Mkt Cap: $0.0B
NPHC
Nutra Pharma Corp.
$0.00
Mkt Cap: $0.0B
NRXCF
NeutriSci International Inc.
$0.00
Mkt Cap: $0.0B
PAIOF
Paion AG
$0.01
Mkt Cap: $0.0B
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
Mkt Cap: $0.0B
STMH
Stem Holdings, Inc.
$0.00
Mkt Cap: $0.0B
TRLFF
Maven Brands Inc.
$0.00
Mkt Cap: $0.0B
VIBEF
Vibe Growth Corporation
$0.05
Mkt Cap: $0.0B
Explore stocks similar to ELLXF for comparison